Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

Salvati A, Melone V, Sellitto A, Rizzo F, Tarallo R, Nyman TA, Giurato G, Nassa G, Weisz A
Breast Cancer Res. 2022 Jul 18;24(1):52. doi: 10.1186/s13058-022-01547-7. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.